Pharma Bio Category

Showing 121–150 of 429 results

  • Placeholder
    Venture

    DiNonA Inc

    Antibody-related therapeutics and diagnostic reagents

  • CRO

    DNALINK

    Clinical research services

  • Equipment

    Dong In Dang Pharm. Co., Ltd.

    Pharmaceuticals

  • Large

    Dong Wha Pharm. Co., Ltd

    Clinical research services

  • Large

    Dong-a Pharm. Co., Ltd.

    Health Functional Food and Food

  • Large

    Dong-A ST

    Pharmaceuticals

  • Venture

    Dongbang Medical

    Dongbang Medical has strived to produce high-quality medical devices since its establishment in 1985. They export their unique brands in high-quality oriental medical devices, fillers, bio-medical devices, and cosmetics devices to around 50 countries.

  • Large

    Dongkoo Bio&Pharma. Co., Ltd.

    Pharmaceuticals

  • Large

    Dongkuk Pharmaceutical Co., Ltd.

    Tissue engineering

  • Large

    Dongkwang Pharmaceutical Co., Ltd.

    Clinical research services

  • CRO

    DreamCIS

    Clinical research services

  • SME

    DXVX

    DXVX is a company that has been involved in various activities. They have launched a probiotic for babies in the global market and have also launched two of their own brand antibiotics in the Chinese antibiotic market, which is the world’s largest. They have also been selected for a national R&D project for technology development for the diagnosis of adult diseases.

  • Venture

    EHL Bio

  • Global

    EISAI Korea Inc

    Clinical research services

  • SME

    Elbridge Abnova Co., Ltd.

    Antibody-related therapeutics and diagnostic reagents

  • Venture

    Elyson Pharmaceutical Co., Ltd

    Cardiovascular disorders

  • Placeholder
  • CMO CDMO

    EuBiologics Co., Ltd.

    Biopharmaceutical development, CRO, CMO, CDMO

  • Venture

    Eutilex

    The core technology that the Eutilex employs for drug development is selecting targets that faithfully enhance or suppress human immune responses. A series of immunomodulatory antibody therapeutics have been developed on that principle to treat cancers and autoimmune diseases.

  • Venture

    ExoCoBio

    Exosomes are nano-vesicles between 30 and 150 nm, secreted by cells for intercellular signaling. They contain a variety of physiologically active substances and play key roles in important cellular processes.

  • Venture

    Exosome Plus

    Exosome Plus was founded in 2018 to drive an extracellular vesicle (EV) revolution, bringing the best EV isolation and characterization platform in the field of regenerative therapy.

  • Venture

    EXOSTEMTECH

    ExoStemTech’s main pipeline is stem cell-derived exosome therapeutics for various indications including osteoarthritis, liver fibrosis, and lung fibrosis. Especially, Cartisome®, the lead asset to treat osteoarthritis, is about to enter a phase 1 clinical trial as of October 2022.

  • Diagnostics

    EYEGENE lnc. LTD

    EYEGENE Inc. is a clinical-stage biopharmaceutical company developing vaccines and new innovative recombinant protein drugs.

  • Venture

    FatiAbGen Co., Ltd.

    FatiAbGen is a company that focuses on innovating novel immunotoxin antibody assets and regulating stem cell fate with cutting-edge technologies.

  • Diagnostics

    Firson Co., Ltd

    Molecular diagnostic products

  • Global

    Fresenius Kabi Korea Ltd.

    Pharmaceuticals

  • Venture

    Future Medicine

    Future Medicine is a company that develops new drugs that regulate various in vivo targets involving nucleosides. They are working on creating globally innovative drugs for diseases without treatments. Their core research capabilities include a variety of neurological disease models, in vivo and in vitro efficacy assessment systems, and a system for mechanistic studies.

Scroll to Top